TY - JOUR
T1 - Time-Varying Association Between Severe Respiratory Syncytial Virus Infections and Subsequent Severe Asthma and Wheeze and Influences of Age at the Infection
AU - The RESCEU Investigators
AU - Wang, Xin
AU - Li, You
AU - Nair, Harish
AU - Campbell, Harry
A2 - Reeves, Rachel M.
A2 - van Wijhe, Maarten
A2 - Fischer, Thea Kølsen
A2 - Simonsen, Lone
A2 - Trebbien, Ramona
A2 - Tong, Sabine
A2 - Bangert, Mathieu
A2 - Demont, Clarisse
A2 - Lehtonen, Toni
A2 - Heikkinen, Terho
A2 - Teirlinck, Anne
A2 - van Boven, Michiel
A2 - van der Hoek, Wim
A2 - van der Maas, Nicoline
A2 - Meijer, Adam
A2 - Fernandez, Liliana Vazquez
A2 - Bøas, Håkon
A2 - Bekkevold, Terese
A2 - Flem, Elmira
A2 - Stona, Luca
A2 - Speltra, Irene
A2 - Giaquinto, Carlo
A2 - Cheret, Arnaud
A2 - Leach, Amanda
A2 - Stoszek, Sonia
A2 - Beutels, Philippe
A2 - Bont, Louis
A2 - Pollard, Andrew
A2 - Openshaw, Peter
A2 - Abram, Michael
A2 - Swanson, Kena
A2 - Rosen, Brian
A2 - Molero, Eva
N1 - Funding Information:
This work was funded by the Innovative Medicines Initiative 2 Joint Undertaking (Grant 116019), which in turn receives support from the European Union's Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations. The supplement is sponsored by RESCEU. The content in this article reflects only the authors' view, and the EC is not responsible for any use that may be made of the information it contains.
Funding Information:
Potential conflicts of interest. H. C. reports grants from the European Union Innovative Medicines Initiative; grants and personal fees from the World Health Organization; and grants from the Bill & Melinda Gates Foundation during the conduct of the study. H. N. reports grants from World Health Organization, grants and personal fees from Sanofi Pasteur, personal fees from Janssen, personal fees from the Bill & Melinda Gates Foundation, personal fees from Reviral, personal fees from AbbVie, and grants from the National Institute of Health Research outside the submitted work. Y. L. reports grants from the World Health Organization; and grants from Wellcome Trust outside the submitted work. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Publisher Copyright:
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
PY - 2022/8/1
Y1 - 2022/8/1
N2 - Background. Early-life severe respiratory syncytial virus (RSV) infection has been associated with subsequent risk of asthma and recurrent wheeze. However, changes in the association over time and the interaction effect of the age at first RSV infection are less well understood. We aimed to assess the time-varying association between RSV and subsequent asthma and wheeze admission and explore how the association was affected by the age at RSV infection. Methods. We retrospectively followed up a cohort of 23 365 children for a median of 6.9 years using Scottish health databases. Children who were born between 2001 and 2013 and had RSV-associated respiratory tract infection (RTI) admissions under 2 years were in the exposed group; those with unintentional accident admissions under 2 years comprised the control group. The Cox proportional-hazards model was used to report adjusted hazard ratios (HRs) of RSV admissions on subsequent asthma and wheeze admissions. We did subgroup analyses by follow-up years. We also explored how this association was affected by the age at first RSV admission. Results. The association was strongest in the first 2 years of follow-up and decreased over time. The association persisted for 6 years in children whose first RSV-RTI admission occurred at 6-23 months of age, with an adjusted HR of 3.9 (95% confidence interval [CI], 3.1-4.9) for the first 2 years, 2.3 (95% CI, 1.6-3.2) for 2 to <4 years, and 1.9 (95% CI, 1.2-2.9) for 4 to <6 years of follow-up. In contrast, the association was only significant for the first 2 years after first RSV-RTI admissions occurring at 0-5 months. Conclusions. We found a more persistent association for subsequent asthma and wheeze in children whose first severe RSV infection occurred at 6-23 months compared to those whose first severe RSV infection occurred at 0-6 months. This provides new evidence for further assessment of the association and RSV intervention programs.
AB - Background. Early-life severe respiratory syncytial virus (RSV) infection has been associated with subsequent risk of asthma and recurrent wheeze. However, changes in the association over time and the interaction effect of the age at first RSV infection are less well understood. We aimed to assess the time-varying association between RSV and subsequent asthma and wheeze admission and explore how the association was affected by the age at RSV infection. Methods. We retrospectively followed up a cohort of 23 365 children for a median of 6.9 years using Scottish health databases. Children who were born between 2001 and 2013 and had RSV-associated respiratory tract infection (RTI) admissions under 2 years were in the exposed group; those with unintentional accident admissions under 2 years comprised the control group. The Cox proportional-hazards model was used to report adjusted hazard ratios (HRs) of RSV admissions on subsequent asthma and wheeze admissions. We did subgroup analyses by follow-up years. We also explored how this association was affected by the age at first RSV admission. Results. The association was strongest in the first 2 years of follow-up and decreased over time. The association persisted for 6 years in children whose first RSV-RTI admission occurred at 6-23 months of age, with an adjusted HR of 3.9 (95% confidence interval [CI], 3.1-4.9) for the first 2 years, 2.3 (95% CI, 1.6-3.2) for 2 to <4 years, and 1.9 (95% CI, 1.2-2.9) for 4 to <6 years of follow-up. In contrast, the association was only significant for the first 2 years after first RSV-RTI admissions occurring at 0-5 months. Conclusions. We found a more persistent association for subsequent asthma and wheeze in children whose first severe RSV infection occurred at 6-23 months compared to those whose first severe RSV infection occurred at 0-6 months. This provides new evidence for further assessment of the association and RSV intervention programs.
KW - age at first RSV infection
KW - asthma
KW - severe RSV infections
KW - time since RSV infection
KW - wheeze
UR - http://www.scopus.com/inward/record.url?scp=85136340992&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiab308
DO - 10.1093/infdis/jiab308
M3 - Journal article
C2 - 34522963
AN - SCOPUS:85136340992
SN - 0022-1899
VL - 226
SP - S38-S44
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
ER -